December 2019

MIMS Full Prescribing Update

New / Revised

Product Name

Section changed
New Abacavir/Lamivudine 600/300 Sun
New Advil 12 Hour Extended Release Tablets
New Air Liquide Air Medical E.P. Grade
New APO-Teriflunomide
New Aripiprazole Generichealth
New Esomeprazole SUN
New FluQuadri (From 6 Months)
New Gabapentin APOTEX Tablets
New Meropenem GH
New Montelukast APOTEX
New Nexium 24HR Once Daily Dosing Capsules
New Novistig
New Polivy
New Riximyo
New Sildenafil APOTEX
New Skyrizi
New Staquis
New Zavicefta
Reinstated Dilart
Revised Aciclovir Intravenous Infusion TGA Date
Revised Adenuric Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Advantan Sponsor
Revised Agrylin Adverse Effects (Undesirable Effects), Overdose
Revised Aimovig Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, List of Excipients, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Amipride Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Andriol Testocaps TGA Date
Revised APO-Ciprofloxacin Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised APO-Fluvoxamine Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions
Revised APO-Levetiracetam TGA Date
Revised APO-Omeprazole Capsules Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised APO-Salbutamol Inhalation Ampoule Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Physicochemical Properties, Special Warnings and Precautions for Use
Revised APO-Sertraline Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised APO-Telmisartan Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use
Revised APO-Terbinafine Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Appese TGA Date
Revised Aratac Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Aricept Name of Medicine, Pharmaceutical Form, TGA Date
Revised Aromasin TGA Date
Revised Atorvastatin GH Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, New contraindication, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use
Revised Avandamet Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions
Revised Azith Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions
Revised B. Braun Midazolam Adverse Effects, Contraindications, Dosage and Administration, Interactions with Other Medicines, Pharmacology, Precautions
Revised Baxter Potassium Chloride, Sodium Chloride and Glucose Intravenous Infusion BP Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised Biological Therapies B-Dose 2 mL Injection Storage
Revised Biological Therapies B-Dose Forte 2.5 mL Injection Storage
Revised Bivalirudin APOTEX Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Bosentan Mylan Qualitative and Quantitative Composition
Revised Botox Special Warnings and Precautions for Use, Therapeutic Indications
Revised Bridion Pharmacological Properties
Revised Brineura Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use
Revised Cabaser Nature and Contents of Container, Special Precautions for Storage
Revised Calcium Chloride Injection (Phebra) List of Excipients, Nature and Contents of Container
Revised Candesartan GH TGA Date
Revised Candesartan HCT GH Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Captopril Sandoz Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Catapres 100 Nature and Contents of Container
Revised Catapres 150 Tablets and Catapres Ampoules Nature and Contents of Container
Revised CeeNU TGA Date
Revised Ceftriaxone-AFT Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Celecoxib GH Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Cephalexin Generichealth TGA Date
Revised Cerezyme Deleted Presentation, Shelf Life, Sponsor
Revised Cernevit Special Warnings and Precautions for Use
Revised Chemmart Sertraline Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised Cilicaine V Adverse Effects, Precautions
Revised Ciproxin IV Adverse Effects, Precautions
Revised Clopidogrel Winthrop Plus Aspirin Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition
Revised CoPlavix Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions
Revised DBL Aciclovir Intravenous Infusion List of Excipients, Qualitative and Quantitative Composition
Revised DBL Cisplatin Injection TGA Date
Revised DBL Diazepam Injection Fertility, Pregnancy and Lactation, Pharmacological Properties
Revised DBL Doxorubicin Hydrochloride Injection List of Excipients
Revised DBL Gemcitabine for Injection TGA Date
Revised DBL Gemcitabine Solution for Injection TGA Date
Revised DBL Hyoscine Injection BP TGA Date
Revised DBL Metronidazole Intravenous Infusion Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised DBL Potassium Dihydrogen Phosphate Concentrated Injection Sponsor
Revised DBL Rocuronium Bromide Injection Pharmaceutical Form
Revised DBL Sodium Nitroprusside Concentrated Injection TGA Date
Revised DBL Vincristine Sulfate Injection Dose and Method of Administration, Qualitative and Quantitative Composition
Revised Decapeptyl TGA Date
Revised Depo-Medrol List of Excipients
Revised Depo-Nisolone TGA Date
Revised Dexmedetomidine Sandoz Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation
Revised Diabex Qualitative and Quantitative Composition
Revised Dostinex Qualitative and Quantitative Composition
Revised Doxorubicin ACC Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Duloxetine Sandoz Special Warnings and Precautions for Use
Revised Duocover Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Qualitative and Quantitative Composition
Revised DuoPlidogrel Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Qualitative and Quantitative Composition
Revised Dupixent Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Durogesic Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Edronax TGA Date
Revised Efexor-XR Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use
Revised Enbrel Pharmaceutical Form
Revised Enlafax-XR Adverse Effects (Undesirable Effects), Dose and Method of Administration, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Erlyand Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Esomeprazole Amneal Capsules Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Esomeprazole RBX Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Estelle-35 ED Sponsor, TGA Date
Revised Evotaz Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication
Revised Extine List of Excipients
Revised Firazyr Shelf Life
Revised Ganfort 0.3/5 Adverse Effects (Undesirable Effects), Contraindications, New contraindication, Pharmaceutical Form, Shelf Life
Revised GANfort PF 0.3/5 Adverse Effects (Undesirable Effects), Nature and Contents of Container, Pharmaceutical Form
Revised Glivec Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Glyxambi Adverse Effects (Undesirable Effects)
Revised Humalog U200 TGA Date
Revised Humalog, Humalog Mix25, Humalog Mix50 TGA Date
Revised Imfinzi Dose and Method of Administration
Revised Imrest Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Inflectra Adverse Effects (Undesirable Effects)
Revised Inlyta Adverse Effects (Undesirable Effects), List of Excipients, Special Warnings and Precautions for Use
Revised I-Pantoprazole Adverse Effects (Undesirable Effects), Contraindications, Deleted Presentation, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Janumet Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Therapeutic Indications
Revised Janumet XR Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Therapeutic Indications
Revised Januvia Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Therapeutic Indications
Revised Kadcyla Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Kalixocin Qualitative and Quantitative Composition
Revised Keppra Oral Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Keytruda Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Klacid Qualitative and Quantitative Composition
Revised Kliogest TGA Date
Revised Kliovance TGA Date
Revised Kyprolis Adverse Effects (Undesirable Effects), Dose and Method of Administration, Incompatibilities, Pharmacological Properties
Revised Levophed 1:1,000 TGA Date
Revised Lincomycin SXP Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Lipigem List of Excipients
Revised Lonsurf Shelf Life
Revised Lyrica Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Meropenem Kabi Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Mersynofen Sponsor
Revised Methotrexate Accord Adverse Effects (Undesirable Effects), Boxed Warnings, Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Mezavant Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Micardis List of Excipients
Revised Milrinone-Baxter Sponsor
Revised Minims Chloramphenicol 0.5% Eye Drops Pharmacological Properties
Revised Mivacron Injection Nature and Contents of Container, Physicochemical Properties
Revised Monofer Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Movapo Adverse Effects (Undesirable Effects)
Revised Movapo Pen Adverse Effects (Undesirable Effects)
Revised Movapo PFS Adverse Effects (Undesirable Effects)
Revised Moviprep Pharmacological Properties, Special Warnings and Precautions for Use
Revised Moviprep Orange Pharmacological Properties, Special Warnings and Precautions for Use
Revised Moxifloxacin APOTEX Special Warnings and Precautions for Use, Therapeutic Indications
Revised Mucosoothe Oral Gel TGA Date
Revised Nebilet TGA Date
Revised Nicotinic Acid Nature and Contents of Container, Qualitative and Quantitative Composition
Revised Nocdurna TGA Date
Revised Norprolac TGA Date
Revised Noten TGA Date
Revised Noxafil Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines
Revised Noxafil Concentrated Injection Adverse Effects (Undesirable Effects)
Revised NuvaRing Contraindications, Special Warnings and Precautions for Use
Revised Olimel Adverse Effects (Undesirable Effects), Dose and Method of Administration
Revised Optiray Deleted Presentation, Nature and Contents of Container, Qualitative and Quantitative Composition
Revised Orfadin Dose and Method of Administration, Special Precautions for Storage
Revised OxyNorm Nature and Contents of Container
Revised OxyNorm Injection TGA Date
Revised Panalgesic Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Pantoprazole Sun TGA Date
Revised Pemzo Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised PeriOlimel Adverse Effects (Undesirable Effects), Dose and Method of Administration
Revised Persantin Ampoules List of Excipients, Nature and Contents of Container
Revised Pharmacor Omeprazole Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Plavix Interactions with Other Medicines and Other Forms of Interactions, Qualitative and Quantitative Composition
Revised Polyvalent Snake Antivenom (Australia, Papua New Guinea) Name of Medicine, Nature and Contents of Container, Pharmaceutical Form, Product Name change, Qualitative and Quantitative Composition
Revised Praluent Adverse Effects (Undesirable Effects), Incompatibilities, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Precedex Adverse Effects (Undesirable Effects), Contraindications, Shelf Life, Special Warnings and Precautions for Use
Revised Precedex Ready to Use Adverse Effects (Undesirable Effects), Contraindications, Shelf Life, Special Warnings and Precautions for Use
Revised Pregabalin GH Nature and Contents of Container, Special Precautions for Storage
Revised Presolol Qualitative and Quantitative Composition
Revised Propofol-Lipuro 1% and 2% Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Prostin VR Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Physicochemical Properties
Revised Proveblue TGA Date
Revised Qlaira TGA Date
Revised Quetiapine GH Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use
Revised Repreve Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Special Precautions for Storage
Revised Rixubis TGA Date
Revised Saizen Dose and Method of Administration, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Shelf Life, Special Precautions for Storage, Special Warnings and Precautions for Use
Revised Saizen 3 Deleted Presentation, Dose and Method of Administration, Special Warnings and Precautions for Use, Sponsor
Revised SalplusF Inhaler Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Sandoz Venlafaxine XR Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use
Revised Seroquel Adverse Effects (Undesirable Effects)
Revised Seroquel XR Adverse Effects (Undesirable Effects)
Revised Sodium Chloride 0.9% Freeflex Pharmacological Properties
Revised Sodium Chloride 0.9% IV Infusion in Viaflo Bag Nature and Contents of Container
Revised Solian Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Solu-Cortef Special Warnings and Precautions for Use, Therapeutic Indications
Revised Somavert Special Precautions for Storage
Revised Talam Nature and Contents of Container, Pharmaceutical Form
Revised Tecentriq Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Terry White Chemists Sertraline Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised Tivicay Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Tixol Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Topamax Adverse Effects (Undesirable Effects)
Revised Tracleer Sponsor
Revised Tracrium Injection TGA Date
Revised Trajenta Adverse Effects (Undesirable Effects)
Revised Trajentamet Adverse Effects (Undesirable Effects)
Revised Tramadol AN Injection TGA Date
Revised Trisequens TGA Date
Revised Uvadex Adverse Effects (Undesirable Effects), Dosage and Administration, Fertility, Pregnancy and Lactation, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Valprease Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Vancomycin Alphapharm List of Excipients
Revised Vecure TGA Date
Revised Vecuronium Sun TGA Date
Revised Velcade Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised Veletri Sponsor
Revised Vincristine Sulfate Injection Interactions with Other Medicines and Other Forms of Interactions
Revised Voltaren List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Special Warnings and Precautions for Use
Revised Voriconazole APOTEX Powder for Injection TGA Date
Revised Xiaflex Sponsor
Revised Zaldiar Special Warnings and Precautions for Use
Revised Zinopril Nature and Contents of Container
Revised Zoloft Special Warnings and Precautions for Use
Revised Zyprexa IM Adverse Effects (Undesirable Effects), Shelf Life, Special Warnings and Precautions for Use
Revised Zyprexa Relprevv Adverse Effects (Undesirable Effects), Shelf Life, Special Warnings and Precautions for Use
Deleted AmoxyClav GH
Deleted Axiron
Deleted Benztropine Omega
Deleted Brevoxyl
Deleted Chelsea-35 ED
Deleted Chemmart Lercanidipine
Deleted Chemmart Ramipril
Deleted Ciprofloxacin AN
Deleted Dacarbazine Sandoz
Deleted Dorzolamide/Timolol Sandoz 20/5
Deleted Fleet Phospho-Soda
Deleted Frusemide Sandoz Injection
Deleted GenRx Clomipramine
Deleted GenRx Gabapentin Capsules
Deleted GenRx Gabapentin Tablets
Deleted Mepreze
Deleted Methaccord
Deleted Midazolam Sandoz
Deleted Oxybutynin Winthrop
Deleted Tenopt
Deleted Terry White Chemists Lercanidipine
Deleted Terry White Chemists Ramipril
Deleted Topiramate GH
Deleted Yeast-free Chromium
Deleted Zaltrap

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au